Follow
Osman Gani
Osman Gani
Other namesA B S M Osman Gani, Gani ABSM Osman
Verified email at farmasi.uio.no - Homepage
Title
Cited by
Cited by
Year
1, 5-Disubstituted 1, 2, 3-triazoles as cis-restricted analogues of combretastatin A-4: Synthesis, molecular modeling and evaluation as cytotoxic agents and inhibitors of tubulin
K Odlo, J Hentzen, JF dit Chabert, S Ducki, OA Gani, I Sylte, M Skrede, ...
Bioorganic & medicinal chemistry 16 (9), 4829-4838, 2008
2162008
Protein kinase inhibition of clinically important staurosporine analogues
OA Gani, RA Engh
Natural product reports 27 (4), 489-498, 2010
1642010
1, 2, 3-Triazole analogs of combretastatin A-4 as potential microtubule-binding agents
K Odlo, J Fournier-Dit-Chabert, S Ducki, OA Gani, I Sylte, TV Hansen
Bioorganic & medicinal chemistry 18 (18), 6874-6885, 2010
1032010
Molecular recognition of Docosahexaenoic acid by peroxisome proliferator-activated receptors and retinoid-X receptor α
OA Gani, I Sylte
Journal of Molecular Graphics and Modelling 27 (2), 217-224, 2008
632008
Are fish oil omega-3 long-chain fatty acids and their derivatives peroxisome proliferator-activated receptor agonists?
OA Gani
Cardiovascular Diabetology 7, 1-6, 2008
612008
Impact of the COVID-19 pandemic on long-term trends in the prevalence of diabetic ketoacidosis at diagnosis of paediatric type 1 diabetes: an international multicentre study …
NH Birkebaek, C Kamrath, JM Grimsmann, K Aakesson, V Cherubini, ...
The Lancet Diabetes & Endocrinology 10 (11), 786-794, 2022
452022
Polygenic overlap and shared genetic loci between loneliness, severe mental disorders, and cardiovascular disease risk factors suggest shared molecular mechanisms
L Rødevand, S Bahrami, O Frei, A Lin, O Gani, A Shadrin, OB Smeland, ...
Translational Psychiatry 11 (1), 3, 2021
402021
Theoretical calculations of the catalytic triad in short-chain alcohol dehydrogenases/reductases
OA Gani, OA Adekoya, L Giurato, F Spyrakis, P Cozzini, S Guccione, ...
Biophysical Journal 94 (4), 1412-1427, 2008
302008
Structural insight into a CE15 esterase from the marine bacterial metagenome
C De Santi, OA Gani, R Helland, A Williamson
Scientific Reports 7 (1), 17278, 2017
242017
Signposts of docking and scoring in drug design
OABSM Gani
Chemical Biology & Drug Design 70 (4), 360-365, 2007
212007
Assessing protein kinase target similarity: Comparing sequence, structure, and cheminformatics approaches
OA Gani, B Thakkar, D Narayanan, KA Alam, P Kyomuhendo, ...
Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1854 (10), 1605-1616, 2015
182015
Structural origins of AGC protein kinase inhibitor selectivities: PKA as a drug discovery tool
E Åberg, B Lund, A Pflug, OA Gani, U Rothweiler, TM de Oliveira, ...
Biological chemistry 393 (10), 1121-1129, 2012
142012
Evaluating the Predictivity of Virtual Screening for A bl Kinase Inhibitors to Hinder Drug Resistance
OA Gani, D Narayanan, RA Engh
Chemical Biology & Drug Design 82 (5), 506-519, 2013
122013
Ligand‐Induced Stabilization and Activation of Peroxisome Proliferator‐Activated Receptor γ
OA Gani, I Sylte
Chemical biology & drug design 72 (1), 50-57, 2008
122008
A collaborative comparison of international pediatric diabetes registries
S Lanzinger, A Zimmermann, AG Ranjan, O Gani, S Pons Perez, ...
Pediatric Diabetes 23 (6), 627-640, 2022
62022
Phenotype-specific differences in polygenicity and effect size distribution across functional annotation categories revealed by AI-MiXeR
AMD Alexey A Shadrin, Oleksandr Frei, Olav B Smeland, Francesco Bettella ...
Bioinformatics, 2020
52020
Annotation-Informed Causal Mixture Modeling (AI-MiXeR) reveals phenotype-specific differences in polygenicity and effect size distribution across functional annotation categories
AA Shadrin, O Frei, OB Smeland, F Bettella, KS O’Connell, O Gani, ...
Biorxiv, 772202, 2019
42019
Data driven polypharmacological drug design for lung cancer: analyses for targeting ALK, MET, and EGFR
D Narayanan, OA Gani, FXE Gruber, RA Engh
Journal of Cheminformatics 9, 1-19, 2017
42017
Årsrapport 2021
T Skrivarhaug, SJ Kummernes, O Gani
42013
Molecular recognition of long chain fatty acids by peroxisome proliferator-activated receptor α
OA Gani, I Sylte
Medicinal chemistry research 18, 8-19, 2009
32009
The system can't perform the operation now. Try again later.
Articles 1–20